orthopedics

Editorial Bioteck

4 November 2019

For the calendar of orthopedic colleagues. Bioteck at the 104th SIOT Congress

From 7 to 10 November 2019 in Rome, at the Rome Cavalieri Waldorf Astoria Congress Centre, the 104th SIOT (Italian Society of Orthopedics and Traumatology) Congress will be held. This year, once again, Bioteck will be present (stand no. 22) to greet and meet the many orthopedic surgeons interested in the innovative solutions for regenerative surgery developed by the company.

The congress will focus on two themes and will address highly topical and advanced issues, well expressed by the chosen title: Complex prosthetic revision surgery of major joints: from reprosthesisation to megaprostheses. Progress in musculoskeletal oncology.

The theme of oncology is a new subject that is somewhat necessary. In recent years, this topic has become increasingly important in the orthopedic field with regard to primitive tumors, but also, and especially, with regard to the treatment of metastatic lesions, which we have to deal with on an almost daily basis.

As decided by the SIOT Board, the Congress venue is Rome, and it will remain such over the next few years, which is what happens in other European countries that host the Congress of the National Society in the capital city to facilitate visitor flow from all over Italy.

This edition of the Congress in Rome is entrusted to the Presidents and Vice-Presidents of the Triveneto region (Pietro Ruggieri, Claudio Zorzi, Araldo Causero, Bruno Magnan and Alberto Momoli). The most important novelty concerns the “format” of the Congress. In fact, as with the Congresses of the major Orthopedic Societies in Europe (EFORT), in the USA (AAOS) and at intercontinental level (SICOT), from now on SIOT will also feature presentations and symposia on all the main topics concerning orthopedic surgery. Therefore, Specialist Societies will not have a dedicated day, but will be called to hold symposia on the chosen topics, according to the project and at the Congress of the parent company SIOT.

About Bioteck S.p.A.

For over 20 years, Bioteck has been involved in regenerative medicine, designing, developing and producing tissue substitutes for use in dentistry, maxillofacial surgery, orthopedics and neurosurgery, using the proprietary Zymo-Teck technological platform. Further information is available on www.bioteck.com and on www.bioteckacademy.com.